3128 Journal of Medicinal Chemistry, 2005, Vol. 48, No. 9
Letters
for valuable discussion, and Ms. Akemi Takahashi for
technical assistance.
Supporting Information Available: Experimental pro-
cedures, NMR data, and ITC profiles. This material is avail-
References
(1) (a) Hershko, A.; Cieshnover, A. The Ubiquitin System. Annu.
Rev. Biochem. 1998, 67, 425-479. (b) Weissman, A. M. Themes
and Variations on Ubiquitination. Nat. Rev. Mol. Cell. Biol. 2001,
2, 169-178.
Figure 4. (A) Proposed model for the complex formed between
4 and sugar-binding domain of Fbs1. (B) Fbs mainly recoginze
Man3GlcNAc2 of high-mannose-type oligosaccharide. (C) The
GlcNAcâ1f2ManR1f6 arm of the complex-type oligosaccha-
ride has reduced affinity due to steric hindrance.
(2) Pickart, C. M. Mechanisms Underlying Ubiquitination. Annu.
Rev. Biochem. 2001, 70, 503-533.
(3) (a) Dashaies, R. SCF and Cullin/Ring H2-Based Ubiquitin
Ligases. Annu. Rev. Cell. Dev. Biol. 1999, 15, 435-467. (b)
Zheng, N.; Schulman, B. A.; Song, L.; Miller, J. J.; Jeffrey, P.
D.; Wang, P.; Chu, C.; Koepp, D. M.; Elledge, S. J.; Pagano, M.;
Conaway, J. W.; Harper, J. W.; Pavletich, N. P. Structure of the
Cul1-Rbx1-Skp1-F box Skp2 SCF Ubiquitin Ligase Complex.
Nature 2002, 416, 703-709.
(4) (a) Winston, J. T.; Koepp, D. M.; Zhu, C.; Elledge, S. J.; Harper,
J. W. A Family of Mammalian F-Box Proteins. Curr. Biol. 1999,
9, 1180-1182. (b) Ilyin, G. P.; Se´randour, A.-L.; Pigeon, C.;
Rialland, M.; Glaise, D.; Guguen-Guillouzo, C. A New Subfamily
of Structurally Related Human F-Box Proteins. Gene 2002, 296,
11-20.
(5) Yoshida, Y.; Chiba, T.; Tokunaga, F.; Kawasaki, H.; Iwai, K.;
Suzuki, T.; Ito, Y.; Matsuoka, K.; Yoshida, M.; Tanaka, K.; Tai,
T. E3 Ubiquitin Ligase That Recognizes Sugar Chains. Nature
2002, 418, 438-442.
(6) Yoshida, Y.; Tokunaga, F.; Chiba, T.; Iwai, K.; Tanaka, K.; Tai,
T. Fbs2 Is a New Member of the E3 Ubiquitin Ligase Family
That Recognizes Sugar Chains. J. Biol. Chem. 2003, 278, 43877-
43884.
(7) Burda, P.; Aebi, M. The Dolichol Pathway of N-Linked Glyco-
sylation. Biochim. Biophys. Acta 1999, 1426, 239-257.
(8) (a) Braakman, I. A Novel Lectin in the Secretory Pathway. An
Elegant Mechanism for Glycoprotein Elimination. EMBO Rep.
2001, 2, 666-668. (b) Hosokawa, N.; Wada, I.; Hasegawa, K.;
Yorihuzi, T.; Trembly, L. O.; Herscovics, A.; Nagata, K. A Novel
ER R-Mannosidase-Like Protein Accelerates ER-Associated
Degradation. EMBO Rep. 2001, 2, 415-422. (c) Oda, Y.; Hosoka-
wa, N.; Wada, I.; Nagata, K. EDEM as an Acceptor of Terminally
Misfolded Glycoproteins Released from Calnexin. Science 2003,
299, 1394-1397. (d) Molinari, M.; Calanca, V.; Galli, C.; Lucca,
P.; Paganetti, P. Role of EDEM in the Release of Misfolded
Glycoproteins from the Calnexin Cycle. Science 2003, 299, 1397-
1400.
(9) (a) Fiedler, K.; Simons, K. The Role of N-Glycans in the Secretory
Pathway. Cell 1995, 81, 309-312. (b) Helenius, A.; Aebi, M.
Intracellular Functions of N-Linked Glycans. Science 2001, 291,
2364-2369. (c) Ellgaard, L.; Molinari, M.; Helenius, A. Setting
the Standards: Quality Control in the Secretory Pathway.
Science1999, 286, 1882-1888.
(10) (a) Thomas, P. J.; Qu, B. H.; Pedersen, P. L. Defective Protein-
Folding as a Basis of Human-Disease. Trends Biochem. Sci.
1995, 20, 456-459. (b) Dobson, C. M. The Structural Basis of
Protein Folding and Its Links with Human Disease. Philos.
Trans. R. Soc. London, Ser. B 2001, 356, 133-145. (c) Horwich,
A. Protein Aggregation in Disease: A Role for Folding Interme-
diates Forming Specific Multimeric Interactions. J. Clin. Invest.
2002, 110, 1221-1232.
(11) Mizushima, T.; Hirao, T.; Yoshida, Y.; Lee, S. J.; Chiba, T.; Iwai,
K.; Yamaguchi, Y.; Kato, K.; Tsukihara, T.; Tanaka, K. Struc-
tural Basis of Sugar-Recognizing Ubiquitin Ligase. Nat. Struct.
Mol. Biol. 2004, 11, 365-370.
Subsequently, the affinities of the partial structures
of Man3GlcNAc2 were evaluated. It was found that the
R1f6 linked tetrasaccharide 5 (entry 5) had an affinity
marginally weaker than that of 4, while the R1f3
linked congener 6 had a drastically reduced affinity
(entry 6). The binding of smaller oligosaccharides such
as 7 (GlcNAc2) and 8 (Man3) was not detectable under
the same conditions. These results indicate that the
R1f6 linked Man residue of the Man3GlcNAc2 core
plays a significant role in the binding of Fbs1. Further-
more, a previously synthesized18b biantennary complex-
type N-glycan (9) was subjected to a binding experiment.
It had a markedly reduced affinity (entry 9), indicating
that substitution at the 2-OH of the R1f6 linked Man
residue caused steric congestion. It is concluded that
both the chitobiose and the R1f6 linked Man residue
are necessary for Fbs1 to recognize a sugar.
We calculated the structure of Man3GlcNAc2 in the
complex with Fbs1 using the AMBER* force field
implemented with the MacroModel program (version
8.1). A branched mannotriose was added to the crystal
structure of chitobiose in the complex with Fbs1, and a
conformational search was conducted with frozen Fbs1
and the chitobiose moiety using Monte Carlo multiple
minimum searching. The most stable conformer for the
Man3 moiety obtained from the calculation is provided
in Figure 4. 4-OH (Figure 4, yellow arrow) of the R1f6
linked Man residue is in contact with Asp216, for which
a chemical shift perturbation was observed on addition
of Man3GlcNAc2. This structure also agrees with our
data obtained from the calorimetric analysis. In par-
ticular, the reduced affinity of the complex-type glycan
can be explained by the steric hindrance caused by the
presence of a bulky trisaccharide (NeuAcR2f3Galâ1f
4GlcNAcâ) at the 2-position of the R1f6 linked Man
residue.
(12) Dam, T. K.; Brewer, C. F. Thermodynamic Studies of Lectin-
Carbohydrate Interactions by Isothermal Titration Calorimetry.
Chem. Rev. 2002, 102, 387-429.
Systematic analysis of the interaction between Fbs1
and synthetic oligosaccharides revealed that Man3-
GlcNAc2 had the strongest affinity. Whereas the major
glycoform translocated into cytosol for ERAD is sup-
posedly Man8GlcNAc2, our results indicate that N-
glycoproteins having Man3GlcNAc2 are more efficiently
recognized by the SCFFbs1 complex. These facts imply
that Man3GlcNAc2 or its derivatives may well be potent
inhibitors of SCFFbs1 complex. Further studies are in
progress along this line.
(13) (a) Matsuo, I.; Wada, M.; Manabe, S.; Yamaguchi, Y.; Otake,
K.; Kato, K.; Ito, Y. Synthesis of Monoglucosylated High-
Mannose-Type Dodecasaccharide, a Putative Ligand for Molec-
ular Chaperone, Calnexin, and Calreticurin. J. Am. Chem. Soc.
2003, 125, 3402-3403. (b) Totani, K.; Matsuo, I.; Takatani, M.;
Arai, M. A.; Hagihara, S.; Ito, Y. Synthesis of Glycoprotein
Molecular Probes for the Analyses of Protein Quality Control
System. Glycoconjugate J. 2004, 21, 69-74. (c) Matsuo, I.; Ito,
Y. Synthesis of an Octamannosyled Glycan Chain, the Key
Oligosaccharide Structure in ER-Associated Degradation. Car-
bohydr. Res. 2003, 338, 2163-2168.
(14) The synthetic details will be reported in due course.
(15) Kanie, O.; Ito, Y.; Ogawa, T. Orthogonal Glycosylation Strategy
in Oligosaccharide Synthesis. J. Am. Chem. Soc. 1994, 116,
12073-12074.
Acknowledgment. We thank Dr. Yukiko Yoshida
for providing the GST-Fbs1 construct, Dr. Koichi Kato